MEMANTIN Mepha Teva dé 7x5/7x10/7x15/7x20mg 28 pce
7680651810055
CH-65181
N06DX01
01.99.0.
Reimbursement limitations:
EBIXA
En début de thérapie, application par ex. d'un test minimental. Première évaluation intermédiaire après trois …
1 / 3
google
Details
- Product number
- 6518101
- CPT
- -
- Packaging group
- 7 + 7 + 7 + 7
- Unit
- Tablette(n)
- Composition
- I) 5 mg: memantini hydrochloridum 5 mg corresp. memantinum 4.15 mg, cellulosum microcristallinum, crospovidonum, talcum, magnesii stearas, Überzug: hypromellosum, macrogolum 3350, lactosum monohydricum 0.473 mg, triacetinum, E 171, pro compresso obducto. II) 10 mg: memantini hydrochloridum 10 mg corresp. memantinum 8.31 mg, cellulosum microcristallinum, crospovidonum, talcum, magnesii stearas, Überzug: hypromellosum, macrogolum 3350, lactosum monohydricum 0.945 mg, triacetinum, E 171, pro compresso obducto. III) 15 mg: memantini hydrochloridum 15 mg corresp. memantinum 12.46 mg, cellulosum microcristallinum, crospovidonum, talcum, magnesii stearas, Überzug: hypromellosum, macrogolum 3350, lactosum monohydricum 1.418 mg, triacetinum, E 171, E 172 (flavum), E 172 (rubrum), E 172 (nigrum), pro compresso obducto. IV) 20 mg: memantini hydrochloridum 20 mg corresp. memantinum 16.62 mg, cellulosum microcristallinum, crospovidonum, talcum, magnesii stearas, Überzug: hypromellosum, macrogolum 3350, lactosum monohydricum 1.89 mg, triacetinum, E 171, E 172 (rubrum), E 172 (flavum), pro compresso obducto.
Articles (1)
Memantin-Mepha Teva 5 mg, 10 mg, 15 mg, 20 mg, Filmtabletten
Filmtabletten
7 + 7 + 7 + 7
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
I
|
5.0 MG | Substance | WIZUS |
|
III
|
15.0 MG | Substance | WIZUS |
|
II
|
10.0 MG | Substance | Wirkstoff (Principe actif) |
|
IV
|
20.0 MG | Substance | WIZUS |
|
II
|
8.31 MG | Substance | WIZUS |
|
I
|
4.15 MG | Substance | Wirkstoff (Principe actif) |
|
IV
|
16.62 MG | Substance | Wirkstoff (Principe actif) |
|
III
|
12.46 MG | Substance | Wirkstoff (Principe actif) |
|
IV
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
IV
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
IV
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
IV
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
IV
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
II
|
- | Substance | HNIDK |
|
IV
|
- | Substance | HNIDK |
|
I
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
III
|
1.418 MG | Substance | HBESI |
|
I
|
- | Substance | HNIDK |
|
IV
|
1.89 MG | Substance | HBESI |
|
II
|
0.945 MG | Substance | HBESI |
|
II
|
- | Substance | HNIDK |
|
III
|
- | Substance | HNIDK |
|
IV
|
- | Substance | HNIDK |
|
I
|
0.473 MG | Substance | HBESI |
|
IV
|
- | Substance | FNIDK |
|
III
|
- | Substance | FNIDK |
|
II
|
- | Substance | FNIDK |
|
I
|
- | Substance | HNIDK |
|
III
|
- | Substance | FTODK |
|
IV
|
- | Substance | FTODK |
|
I
|
- | Substance | FNIDK |
|
IV
|
- | Substance | FTODK |
|
III
|
- | Substance | FTODK |
|
III
|
- | Substance | FTODK |
Reimbursement information
Public price
CHF 46.45
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/09/2024
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 65181
- Drug name
- Memantin-Mepha Teva, Filmtabletten
- Galenic form
- FILM
- ATC Code
- N06DX01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 06/11/2014
- Authorization expiration date
- 31/12/9999
- IT number
- 01.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- MEMANTIN Mepha Teva dé 7x5/7x10/7x15/7x20mg 28 pce
- Description (DE)
- MEMANTIN Mepha Teva St 7x5/7x10/7x15/7x20mg 28 Stk
- Market launch
- 06/11/2014
- Narcotic (BTM)
- No